Niagen Bioscience (NAGE) Stock Price, Quote, News & History | Benzinga

Niagen Bioscience Inc (NAGE) Stock Price, Quote, News & History

NAGENASDAQ

Trade with Public

Trade with Public

$3.26

0.051.56%

Last update: Aug 28, 9:48 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.21

Close

-

Volume / Avg.

28.24K / 713.94K

Day Range

$3.20 - $3.23

52 Wk Range

2.87 - 10.52

Market Cap

$259.64M

P/E Ratio

16.89

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

8.31%

Days to Cover

5.36

Recent Niagen Bioscience Inc News

Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures up, Dow futures gain 0.1% as Snap (NYSE: SNAP) shares fall 10.5%, Fastly (NASDAQ: FSLY) down 21.6%, and other stocks decline in pre-market trading.

Avi Kapoor

Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs (UPDATED)

Niagen Bioscience reaffirms 2026 sales outlook after first-quarter revenue and profit rose alongside investments in injections and skincare.

Eva Mathew

Fastenal, Replimune Group, Children's Place And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures lower, with Dow futures down 150 points. Fastenal shares dip 4% after meeting earnings estimate. Other stocks also down.

Avi Kapoor

Why Veeva Systems Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Shares of Veeva Systems Inc (NYSE: VEEV) gained 11.3% in pre-market trading on upbeat Q4 results and FY27 guidance above estimates.

Avi Kapoor

Niagen Bioscience Rallies 18% After Hours: Here's Why

Niagen Bioscience Inc. surged in after-hours trading after reporting record 2025 results, while maintaining a cautious outlook for 2026.

Mohd Haider

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

5.95M

Investing Cash Flow (TTM)

5.03M

Financing Cash Flow (TTM)

-4.71M

Free Cash Flow (TTM)

5.67M

Capital Expenditure (TTM)

-275.00K

Net Change in Cash (TTM)

6.27M

Analyst Trends and Forecast

2

Mar

2

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$189.58M

PE Ratio (TTM)

16.89

PE Ratio (FWD)

22.94

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.11

PB Ratio (TTM)

3.08

Earnings Yield % (TTM)

5.92%

Earnings Yield % (FWD)

4.36%

EV / EBITDA (TTM)

18.45

Price / EBITDA (TTM)

26.47

Price / Free Cash Flow (TTM)

47.94

Book Value / Share

$1.04

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$6.00K

Total Cash

$66.74M

Debt to Equity

0.03

Issuance of Debt (TTM)

-$6.00K

Repayment of Debt (TTM)

-$6.00K

Key Statistics

Open

$3.21

Close

-

Volume / Avg.

28.24K / 713.94K

Day Range

$3.20 - $3.23

52 Wk Range

2.87 - 10.52

Market Cap

$259.64M

P/E Ratio

16.89

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

8.31%

Days to Cover

5.36

About

Sector

Consumer Staples

Industry

Personal Products

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven t...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Niagen Bioscience (NAGE) stock?

A

You can purchase shares of Niagen Bioscience (NASDAQ:NAGE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Niagen Bioscience (NAGE) competitors?

A

Other companies in Niagen Bioscience’s space includes: Unilever PLC (NYSE:UL), The Estee Lauder Companies Inc (NYSE:EL), Kenvue Inc (NYSE:KVUE), e.l.f. Beauty Inc (NYSE:ELF) and Interparfums Inc (NASDAQ:IPAR).

Q

What is the forecast, or price target, for Niagen Bioscience (NAGE) stock?

A

Niagen Bioscience has a consensus price target of $14.67.

Q

What is the current price for Niagen Bioscience (NAGE)?

A

The stock price for Niagen Bioscience (NASDAQ: NAGE) is $3.26 last updated August 28, 2026 at 9:48 AM EDT.

Q

Does Niagen Bioscience (NAGE) pay a dividend?

A

There are no upcoming dividends for Niagen Bioscience.

Q

When is Niagen Bioscience (NASDAQ:NAGE) reporting earnings?

A

Niagen Bioscience does not have any upcoming earnings scheduled.

Q

Is Niagen Bioscience (NAGE) going to split?

A

There is no upcoming split for Niagen Bioscience.

Q

What sector and industry does Niagen Bioscience (NAGE) operate in?

A

Niagen Bioscience is in the Consumer Staples sector and Personal Products industry. They are listed on the NASDAQ.